Tag: American Society of Clinical Oncology

Survey: Pediatric Oncology Providers Favor Patients’ Access to Medical Cannabis

By Paul Armentano, NORML Deputy Director More than nine in ten pediatric oncology providers with opinions favor patients’ access to cannabis therapy, according to survey data provided this week at the 2016 annual meeting of the American Society of Clinical Oncology. Investigators from various US cancer treatment centers surveyed 654 pediatric oncology providers, including physicians …

Continue reading